市场调查报告书
商品编码
1267486
拉丁美洲皮下注射器和针头市场——按类型、使用性别、最终用途、全球预测,2023-2032 年Latin America Hypodermic Syringes & Needles Market - By Type, By Usability, By Application, By End-use, & Global Forecast, 2023 - 2032 |
由于在拉丁美洲经济体中进行的手术数量不断增加,预计从 2023 年到 2032 年,拉丁美洲皮下注射和针头市场将遵循积极的轨迹。
一份报告显示,2020 年,巴西小灵通因外科手术住院的人数超过 400 万。
随着老年人口的不断增长,我们看到对改善生活质量的外科手术的需求不断增加。 技术创新还促进了在治疗相关疾病方面安全、无菌和微创针头外科手术的发展。
总体而言,拉丁美洲皮下注射器和针头行业在类型、可用□□性、应用、最终用途和地区方面进行了细分。
按类型划分,由于人们对通过注射器进行药物治疗的意识不断增强,预计注射器细分市场将从 2023 年到 2032 年出现增长。 此外,拉美各国政府实施的关于使用无菌一次性注射器的几项安全指南得到了医疗保健行业主要参与者的大力支持。
可重复使用的皮下注射器和针头具有多重优势,例如价格实惠、质量高、抗拉强度高和更清洁的环境足迹,因此在未来十年可以使用的地方它们将引起极大兴趣。将收集 此外,到 2032 年,环保消耗品和减少浪费等产品优势将刺激该行业的增长。
根据应用,血液采集行业预计到 2032 年的复合年增长率将超过 3.5%。 预计拉丁美洲地区献血和血小板输注运动的显着改善将对该领域的前景产生积极影响。
考虑到最终用途,到 2032 年,诊断中心行业的价值可能超过 940 亿美元。 呼吸系统疾病、血液相关疾病、糖尿病和高血压的增加预计将在未来几年增加对此类中心的需求。 由于慢性疾病的增加,血液和标本采集量的增加预计将在未来几年进一步使这些设施受益。
按国家/地区划分,墨西哥皮下注射器和针头市场预计在预测期内将出现显着增长。 技术进步、医疗保健支出增加和人口迅速老龄化等因素将影响该地区的收入份额。 此外,医疗保健设施、诊断治疗和慢性病的增长预计将推动该国的增长。
Latin America Hypodermic Syringes & Needles Market is estimated to depict a positive trajectory during 2023-2032, owing to the increasing number of surgeries taking place in the Latin American economies. As per reports, there were more than 4 million hospitalizations for surgical procedures in the Brazilian PHS in 2020.
Constantly rising geriatric population has been witnessing a growing demand for surgical procedures to improve the quality of life. Besides, technological innovations have favored the evolution of surgical procedures that incorporate safe, sterile, and less invasive needles in treating related ailments.
Overall, the Latin America Hypodermic Syringes & Needles industry is segmented in terms of type, usability, application, end-use and region.
Based on type, the syringes segment will demonstrate growth during 2023-2032 owing to the increasing awareness regarding administering medications using syringes. Besides, the key players operating in the healthcare business space are gaining huge traction owing to several safety guidelines imposed by various LATAM governments regarding the use of sterile single-use syringes.
By usability, the reusable segment will gain huge prominence over the next decade owing to the multiple advantages offered by reusable hypodermic syringes and needles such as affordability, high quality, tensile strength, and a cleaner environmental footprint. In addition, product benefits such as environment-friendly supplies and less waste creation will spur the segment growth by 2032.
In terms of application, the blood collection segment will exhibit over 3.5% CAGR through 2032. Significant improvement in blood donations & platelet transfusion campaigns in the Latin America region will positively influence the segmental outlook.
Considering the end-use, the diagnostic centers segment will be valued at over USD 94 billion by 2032. Increasing incidences of respiratory disorders, blood-related diseases, diabetes, and hypertension will spur the demand for such centers over the coming years. The increased blood & specimen collection volume due to rising cases of chronic illnesses is further set to benefit these facilities in the coming years.
Country-wise, the Mexico hypodermic syringes & needles market will record substantial growth during the forecast spell. Factors such as increasing modern technologies, rising healthcare expenditures, and a rapidly ageing population will influence the regional revenue share. Besides, the increasing number of healthcare facilities, diagnostic therapy, and chronic diseases will boost the country growth.